These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

619 related items for PubMed ID: 28779384

  • 1. Macrometastasis in Papillary Thyroid Cancer Patients is Associated with Higher Recurrence in Lateral Neck Nodes.
    Kim SY, Kim BW, Pyo JY, Hong SW, Chang HS, Park CS.
    World J Surg; 2018 Jan; 42(1):123-129. PubMed ID: 28779384
    [Abstract] [Full Text] [Related]

  • 2. The presence of cancerous nodules in lymph nodes is a novel indicator of distant metastasis and poor survival in patients with papillary thyroid carcinoma.
    Chen L, Zhu Y, Zheng K, Zhang H, Guo H, Zhang L, Wu K, Kong L, Ruan W, Hu J, Zhang X, Chen X.
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):1035-1042. PubMed ID: 28204971
    [Abstract] [Full Text] [Related]

  • 3. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC, Na SY, Park GC, Han JH, Kim SW, Eun YG.
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery.
    Conzo G, Mauriello C, Docimo G, Gambardella C, Thomas G, Cavallo F, Tartaglia E, Napolitano S, Varriale R, Rossetti G, Fei L, Santini L.
    Int J Surg; 2014 Feb; 12 Suppl 1():S194-7. PubMed ID: 24862675
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH, Shen WT, Gosnell J, Duh QY.
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [Abstract] [Full Text] [Related]

  • 6. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
    Dobrinja C, Troian M, Cipolat Mis T, Rebez G, Bernardi S, Fabris B, Piscopello L, Makovac P, Di Gregorio F, de Manzini N.
    Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
    [Abstract] [Full Text] [Related]

  • 7. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
    Baek SK, Jung KY, Kang SM, Kwon SY, Woo JS, Cho SH, Chung EJ.
    Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
    [Abstract] [Full Text] [Related]

  • 8. Papillary thyroid cancer: controversies in the management of neck metastasis.
    Davidson HC, Park BJ, Johnson JT.
    Laryngoscope; 2008 Dec; 118(12):2161-5. PubMed ID: 19029855
    [Abstract] [Full Text] [Related]

  • 9. Prognostic Implications of Lymph Node Yield in Central and Lateral Neck Dissections for Well-Differentiated Papillary Thyroid Carcinoma.
    Heaton CM, Chang JL, Orloff LA.
    Thyroid; 2016 Mar; 26(3):434-40. PubMed ID: 26825749
    [Abstract] [Full Text] [Related]

  • 10. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH, Kuo SF, Hsueh C, Chao TC, Lin JD.
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [Abstract] [Full Text] [Related]

  • 11. Autotransplantation of Inferior Parathyroid glands during central neck dissection for papillary thyroid carcinoma: a retrospective cohort study.
    Wei T, Li Z, Jin J, Chen R, Gong Y, Du Z, Gong R, Zhu J.
    Int J Surg; 2014 Dec; 12(12):1286-90. PubMed ID: 25448646
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcomes of central neck dissection for cN0 papillary thyroid carcinoma.
    Giordano D, Frasoldati A, Gabrielli E, Pernice C, Zini M, Castellucci A, Piana S, Ciarrocchi A, Cavuto S, Barbieri V.
    Am J Otolaryngol; 2017 Dec; 38(5):576-581. PubMed ID: 28599790
    [Abstract] [Full Text] [Related]

  • 13. The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.
    Jeon MJ, Yoon JH, Han JM, Yim JH, Hong SJ, Song DE, Ryu JS, Kim TY, Shong YK, Kim WB.
    Eur J Endocrinol; 2013 Feb; 168(2):219-25. PubMed ID: 23161752
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.
    Hu D, Lin H, Zeng X, Wang T, Deng J, Su X.
    World J Surg; 2020 May; 44(5):1498-1505. PubMed ID: 31863139
    [Abstract] [Full Text] [Related]

  • 16. The stratification of patient risk depending on the size and ratio of metastatic lymph nodes in papillary thyroid carcinoma.
    Hong YR, Lee SH, Lim DJ, Kim MH, Jung CK, Chae BJ, Song BJ, Bae JS.
    World J Surg Oncol; 2017 Apr 04; 15(1):74. PubMed ID: 28376807
    [Abstract] [Full Text] [Related]

  • 17. Selective lateral compartment neck dissection for thyroid cancer.
    Welch K, McHenry CR.
    J Surg Res; 2013 Sep 04; 184(1):193-9. PubMed ID: 23816244
    [Abstract] [Full Text] [Related]

  • 18. Lymph node yield in the initial central neck dissection (CND) associated with the risk of recurrence in papillary thyroid cancer: A reoperative CND cohort study.
    Yu ST, Ge JN, Sun BH, Wei ZG, Xiao ZZ, Zhang ZC, Chen WS, Li TT, Lei ST.
    Oral Oncol; 2021 Dec 04; 123():105567. PubMed ID: 34710736
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
    Zhao H, Huang T, Li H.
    Surgery; 2019 Jul 04; 166(1):55-60. PubMed ID: 30876667
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.
    Mercante G, Frasoldati A, Pedroni C, Formisano D, Renna L, Piana S, Gardini G, Valcavi R, Barbieri V.
    Thyroid; 2009 Jul 04; 19(7):707-16. PubMed ID: 19348581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.